Raindance Technologies

Homology Medicines Inc. is a clinical-stage biotechnology company based in Bedford, MA, dedicated to advancing genetic medicines aimed at providing durable treatments for individuals affected by rare genetic conditions. Their work is grounded in a proprietary AAVHSC vector platform, which allows for the precise delivery of genetic material, ensuring a strong scientific foundation for each program. With a commitment to patient-first values, the company emphasizes integrity in research and collaborative partnerships with healthcare providers. By focusing on innovation through the combination of deep scientific insight and adaptive manufacturing processes, Homology Medicines is actively developing targeted programs, such as HMI-103 for phenylketonuria, in pursuit of addressing various lysosomal storage disorders and blood-related conditions. Generated from the website

Madrigal Pharmaceuticals, based in Conshohocken, Pennsylvania, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with a significant unmet medical need. Their lead clinical candidate, resmetirom, is currently undergoing studies for the treatment of patients with NASH who have significant liver fibrosis or compensated cirrhosis. With a focus on improving care for individuals affected by NASH, Madrigal Pharmaceuticals aims to address the lack of FDA-approved treatments for this condition through their research and development efforts. Their commitment to advancing novel therapies underscores their mission to make a meaningful impact on the lives of patients with NASH.Generated from the website